L101 - Groundbreaking Validation of the FirstLook Lung Test
In this case control study, participants with and without lung cancer were enrolled and provided blood samples to develop the FirstLook™ Lung test. The primary objective of the study was to train and validate a high performing blood-based lung cancer screening test for lung cancer early detection.
STATUS: The results of the L101 trial have been published in Cancer Discovery. Enrollment is closed.
CASCADE-LUNG (Cancer Screening Assay using DELFI) - L201
CASCADE-LUNG is a prospective cohort validation study of the FirstLook™ Lung test in individuals eligible for lung cancer screening. This large-scale study will help determine the ability of our simple, blood-based screening technology to detect lung cancer accurately and reliably.
STATUS: Enrollment is closed.
L301 - FIRSTLUNG
FIRSTLUNG is a prospective, cluster randomized controlled trial to observe the impact of the FirstLook™ Lung cancer screening test on lung cancer screening utilization in primary care practices. Approximately 62 practices are expected to be enrolled.
STATUS: Enrollment is closed.